Navigation Links


synergystic in Medical Technology

Viventia biotech reports synergystic effect of its Proxinium antibody in combinaton with chemotherapy and radiation

- Results Reported at the American Association for Cancer Research (AACR) Annual Meeting - TORONTO, April 18, 2007 /PRNewswire/ - Viventia Biotech Inc., a privately held biopharmaceutical company advancing a portfolio of novel antibody products focused on cancer, today announced results of in vitr...
Other TagsGilafoetuslabelsOTCOTCgraveICIICIICIICIICIICIICIICIICI
(Date:11/25/2009)...calEndorsements,Business,andPressJoinEfforttoEduca...re/--Onceagain,theNationalBipolarFoundationandtheM...eir"Safe,tilStable"program,whichisnowbeingwidelyac...rder.Today,theNationalBipolarFoundationreceivedapr...ilfromtheLt.GovernorofLouisianaMitchLandrieu.TheNa...
(Date:11/25/2009)...ound evidence of a statistically significant survi... whose estrogen receptor (ER)-positive tumors had ...ine-118 (ER-alpha S118-P), according to a brief co...ournal of the National Cancer Institute . , Appr...o tamoxifen. Preclinical studies have shown that E...
(Date:11/25/2009)...se blood pressure? This simple question has been ... Stress-related gene Modulates High Blood Pressure...re? This simple question has been the focus of in...as for the first time established a link between a...ponse to stress in mice as well as humans. The stu...
(Date:11/25/2009)...sed to fight rheumatoid arthritis, could help newl...EDNESDAY, Nov. 25 (HealthDay News) -- A drug commo...atoid arthritis now also shows some promise in hel.... , The drug, rituximab (Rituxan), helped patie... though the disease had destroyed some of their pa...
(Date:11/25/2009)...ss could lead mothers to overlook needed care, stu...ay News) -- A mother,s depression can worsen her c...heir six-month study of 262 black mothers and thei...ore depressive symptoms had more frequent asthma s...essive symptoms had less frequent asthma symptoms....
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Mom's Depression May Worsen Child's Asthma 2
(Date:11/24/2009)...is release is available in Spanish . , The ...er levels of inflammatory substances in the blood,...as shown by a research project of the University o... scientist at the School of Pharmacy. , The proj...dy in relation to the control of body weight and i...
(Date:11/23/2009)... Cambridge, Mass. November 23, 2009 Applied math...n lily ( Hosta lancifolia ), a characteristic long...y packed ripples along the edges. The simple cause...sulting from bending during differential growthwas...retching foam ribbons. , Haiyi Liang, a postdoct...
(Date:11/23/2009)...INE, Calif. -- More than 160 participants gathered...es Keck FUTURES INITIATIVE conference. This year,s...ntists, engineers, and medical researchers to expl... surrounding the emerging field of synthetic biolo...biology at Princeton University and this year,s co...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2EHE International Supports The Michael J Fox Foundation for Parkinsons Research 53849 1EHE International Supports The Michael J Fox Foundation for Parkinsons Research 53849 2Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 1Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 2Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 3Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 4Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 5Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 6Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference 53844 1Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference 53844 2
Other Contentsnonvascularnormalizationnormalizationnormalizationnormalizationnorthernnorthernnorthernnorthernnorthernnostrilnostrilnotochordterminusterminusterminusacidsacidsacidsacidsacidsacidsacidsacidsacidsnucleicnucleicnucleicnucleicnucleicnucleicnucleicnucleicnucleic